Katsura Y, Inoue Y, Nishino S, Tomoi M, Itoh H, Takasugi H
New Drug Research Laboratories, Fujisawa Pharmaceutical Co., Ltd., Osaka, Japan.
Chem Pharm Bull (Tokyo). 1992 Jun;40(6):1424-38. doi: 10.1248/cpb.40.1424.
A series of imidazo[1,2-a]pyridinylalkylbenzoxazole derivatives was synthesized and tested for histamine H2-receptor antagonist, gastric antisecretory and antiulcer activities. Some of 2-amino-6-[2-(imidazo[1,2-a]pyridin-2-yl)ethyl]benzoxazole derivatives were found to have good pharmacological activities. Among them, 2-amino-6-[2-(7-methoxy-3-methylimidazo[1,2-a]pyridin-2-yl)ethyl] benzoxazole (II-11) and 2-acetamido-6-[2-(7-methylimidazo[1,2-a]pyridin-2-yl)ethyl] benzoxazole (II-38) showed potent antisecretory and cytoprotective activity. The structure-activity relationships of these compounds are discussed.
合成了一系列咪唑并[1,2 - a]吡啶基烷基苯并恶唑衍生物,并对其进行组胺H2受体拮抗剂、胃抗分泌和抗溃疡活性测试。发现一些2 - 氨基 - 6 - [2 - (咪唑并[1,2 - a]吡啶 - 2 - 基)乙基]苯并恶唑衍生物具有良好的药理活性。其中,2 - 氨基 - 6 - [2 - (7 - 甲氧基 - 3 - 甲基咪唑并[1,2 - a]吡啶 - 2 - 基)乙基]苯并恶唑(II - 11)和2 - 乙酰氨基 - 6 - [2 - (7 - 甲基咪唑并[1,2 - a]吡啶 - 2 - 基)乙基]苯并恶唑(II - 38)表现出强效的抗分泌和细胞保护活性。讨论了这些化合物的构效关系。